These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 16036099

  • 1. Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action.
    Reginster JY, Sarlet N, Lejeune E, Leonori L.
    Curr Osteoporos Rep; 2005 Mar; 3(1):30-4. PubMed ID: 16036099
    [Abstract] [Full Text] [Related]

  • 2. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY, Deroisy R, Jupsin I.
    Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
    [Abstract] [Full Text] [Related]

  • 3. Strontium ranelate in osteoporosis.
    Reginster JY.
    Curr Pharm Des; 2002 Feb; 8(21):1907-16. PubMed ID: 12171530
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
    Manette C, Collette J, Sarlet N, Tancredi A, Zegels B, Reginster JY.
    Curr Med Chem; 2006 Feb; 13(13):1585-90. PubMed ID: 16787205
    [Abstract] [Full Text] [Related]

  • 5. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY, Lecart MP, Deroisy R, Lousberg C.
    Expert Opin Investig Drugs; 2004 Jul; 13(7):857-64. PubMed ID: 15212623
    [Abstract] [Full Text] [Related]

  • 6. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S.
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [Abstract] [Full Text] [Related]

  • 7. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S, Vai S.
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [Abstract] [Full Text] [Related]

  • 8. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
    Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY.
    N Engl J Med; 2004 Jan 29; 350(5):459-68. PubMed ID: 14749454
    [Abstract] [Full Text] [Related]

  • 9. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
    Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ.
    J Bone Miner Res; 2006 Apr 29; 21(4):536-42. PubMed ID: 16598373
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ.
    Arthritis Rheum; 2008 Jun 29; 58(6):1687-95. PubMed ID: 18512789
    [Abstract] [Full Text] [Related]

  • 13. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ.
    Bone; 2006 Feb 29; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [Abstract] [Full Text] [Related]

  • 14. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
    Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY.
    Osteoporos Int; 2009 Oct 29; 20(10):1663-73. PubMed ID: 19153678
    [Abstract] [Full Text] [Related]

  • 15. Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action.
    Kendler DL.
    Curr Osteoporos Rep; 2006 Mar 29; 4(1):34-9. PubMed ID: 16527006
    [Abstract] [Full Text] [Related]

  • 16. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E, Chabadel A, Saltel F, Jurdic P.
    Bone; 2008 Jan 29; 42(1):129-38. PubMed ID: 17945546
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E.
    Curr Opin Rheumatol; 2006 Jun 29; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.